Tech Company Financing Transactions
Tagomics Funding Round
Tagomics, operating out of Cambridge, raised $8.5 million from Calculus Capital, Agilent Technologies and Illumina Ventures.
Transaction Overview
Company Name
Announced On
2/21/2024
Transaction Type
Venture Equity
Amount
$8,480,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to accelerate its scientific research and product development, with the goal of delivering improvements in cancer and other diseases' diagnosis and treatment.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
Granta Park, The Cori Building, Little Abington
Cambridge, CB21 6GQ
UK
Cambridge, CB21 6GQ
UK
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Tagomics' proprietary multiomic platform unlocks disease-associated biomarkers from a range of biological sources including genetic, epigenetic, and fragmentomic features. In combination with our advanced bioinformatic and machine learning approaches our platform provides unique biological insights and offers a step change in genomics-based disease profiling and diagnosis.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Kirk Malloy
Chief Executive Officer
Jack Kennefick
Chief Financial Officer
Elizabeth Dainty
Chief Scientific Officer
Robert Neely
Chief Technical Officer
Debora Lucarelli
Browse more venture capital transactions:
Prev: 2/21/2024: Alodokter venture capital transaction
Next: 2/21/2024: BridgeCare venture capital transaction
Share this article
About Our VC Transactions Data
Our team works diligently to document every notable VC transaction. VC investment data records reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs